The Daily Startup: Deciphera Pharmaceuticals Raises $75M Series B Round

dailystartup_D_20090806101628.jpgArt by Mike Lucas

Deciphera Pharmaceuticals LLC has raised a $75 million Series B round to develop cancer therapies that could be less susceptible to resistance than some existing treatments, Brian Gormley reports for Dow Jones VentureWire. New investor New Leaf Venture Partners led the round. Drugs known as kinase inhibitors treat several cancers, but resistance eventually builds up to those drugs. Deciphera expects resistance to develop more slowly to its kinase inhibitors compared with others on the market.

ALSO IN TODAY’S VENTUREWIRE (subscription required):

Cruise Automation Inc., a San Francisco startup working on technology that would enable human-operated cars to go into “highway autopilot” mode, has raised $12.5 million in a Series A round that was led by Spark Capital.

PokitDok Inc., health-care technology provider, has closed a $34 million round of financing in August, said it appointed several executives, including a chief financial officer.

Nabriva AG, an antibiotics company, had its shares climb 29% in their first day of trading following the company’s initial public offering. Vienna-based Nabriva issued 9 million American Depository Shares at a price of $10.25 per ADS, bringing in $92.3 million for the company from the offering. The company’s shares traded closed at $13.24 at the end of Friday.

Penumbra Inc., a medical-device company, saw a day-one pop on the New York Stock Exchange on Friday, with an initial stock price of $30 per share jumping to $40 per share as markets opened. The company, which trades under the symbol “PEN,” put 4 million shares of stock on offer, raising $120 million.

(VentureWire is a daily newsletter with comprehensive analysis of all the investments, deals and personnel moves involving startups and their venture backers. For a two-week trial, visit, scroll to the bottom and click “try for free.”)


Silicon Valley Wants High-Skilled Immigration on Campaign Agenda. Debate about immigration has emerged in the presidential race, but, a lobbying group created by Mark Zuckerberg and other tech founders, is trying to get talk about more high-tech workers being able to work in the U.S. into the political discussion, The Wall Street Journal’s Marie-Astrid Langer reports. Tech companies frequently say that the current immigration system is holding them back, according to Todd Schulte, president of

Uber Meets Its Match in France. Six-year-old ride-hailing company Uber Technologies Inc. has expanded across the globe, but its fight in France is among its most intense and has raised questions about its usual ability to break free of regulatory impediments or make peace with government officials, the WSJ’s Sam Schechner reports. Two of Uber’s top executives in Paris are set to go to trial to face charges that include enabling illegal taxi services.

Snapchat Is in Fashion With Burberry. British luxury-goods house Burberry Group decided to debut its latest collection on Snapchat a day before the clothing hit the runway at London Fashion Week, the WSJ’s Christina Passariello reports. Snapchat also is curating a Live Show of crowd-sourced images from Burberry’s event. The show on Snapchat will disappear after 24 hours.

Write to Mike Billings at Follow him on Twitter at @mbillings